Additional analyses support superior efficacy of nirmatrelvir/ritonavir over molnupiravir for COVID-19.

Li-Chen ChangI-Wen Chen Kuo-Chuan Hung

Published in: Journal of medical virology (2024)

Keyphrases

coronavirus disease

sars cov

antiretroviral therapy

respiratory syndrome coronavirus